All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99

ViewsDownloads

Relative Articles

More...

Modelling Marek's Disease Virus (MDV) infection: parameter estimates for mortality rate and infectiousness

DOI: 10.1186/1746-6148-7-70

Full-Text   Cite this paper   Add to My Lib

Abstract:

Our analyses show that strains of higher virulence have a higher viral shedding rate, and more rapidly kill hosts. Vaccination enhances host life expectancy but does not significantly reduce the shedding rate of the virus. While the primary latent period of the virus does not vary with challenge strain nor vaccine treatment of host, the time until the maximum viral shedding rate is increased with vaccination.Our approach provides the tools necessary for a formal analysis of the evolution of virulence in MDV, and potentially simpler and cheaper approaches to comparing the virulence of MDV strains.Marek's Disease Virus (MDV) is an oncogenic poultry herpesvirus of considerable economic importance to the poultry industry. Virus strains have become increasingly virulent since the 1960s [1,2]. The causes of this viral evolution are unclear [3]. Quantification of patterns of viral shedding and virus-induced host mortality are necessary for a rigorous understanding of the epidemiology of a disease, not least to identify increases in virulence. Here we develop methods to do this.MDV is an airborne pathogen with infection occurring via inhalation [4]. Virus shedding occurs by infected feather follicle epithelium [5]. The resulting dust and dander from dead stratified cells and moulted feathers can then remain in the environment and act as a reservoir for chicken infection. Clinical signs are varied and result in significant morbidity and mortality depending on host genetic susceptibility and virulence of the MDV strain [6]. Symptoms include polyneuritis (an enlargement of multiple peripheral nerves), visceral lymphoma (tumours affecting organs such as the heart, liver, spleen etc.), acute transient paralysis, immunosuppression, brain oedema and acute rash. There has been a change in the types of clinical signs since the disease was first noted [7,8], when chronic polyneuritis was the only sign. Since then, the list of clinical signs described above expanded gradually over the

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133